Bank of New York Mellon
MIRA icon

Bank of New York Mellon’s MIRA Pharmaceuticals MIRA Stock Holding History

Bank of New York Mellon’s Portfolio MIRA Stock Details MIRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-20,001
Closed -$12.7K – 4141
2024
Q2 		$12.7K Buy
+20,001
New +$16.4K ﹤0.01% 4093

Other funds holding MIRA

CSI
Cross Staff Investments Pittsford, New York $178M AUM 21.21% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
SEM
Suncoast Equity Management Tampa, Florida $798M AUM 14.62% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return
SSA
Schonfeld Strategic Advisors New York $14.2B AUM 37.17% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
APP
Avantax Planning Partners Dubuque, Iowa $4.02B AUM 20% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
FAB
First American Bank Dundee, Illinois $1.79B AUM 30.35% 1-Year Est. Return
PWM
Praetorian Wealth Management Carmel, California $580M AUM 19.43% 1-Year Est. Return

Bank of New York Mellon's MIRA Position: Q3 2024 in Review

Bank of New York Mellon sold out of MIRA Pharmaceuticals (MIRA) in Q3 2024, closing a stake of 20,001 shares — an estimated $12.7K sold.

Bank of New York Mellon first reported a position in MIRA in Q2 2024 and held it in 1 quarter. The position peaked at $12.7K in Q2 2024. 15 funds tracked by Wall St. Rank hold MIRA as of Q3 2024.

  • Bank of New York Mellon reported no remaining MIRA Pharmaceuticals position as of Q3 2024 after selling out during the quarter.
  • Bank of New York Mellon sold 20,001 MIRA Pharmaceuticals shares in Q3 2024, an estimated $12.7K.
  • Bank of New York Mellon first reported a position in MIRA Pharmaceuticals in Q2 2024 and held it in 1 quarter.
  • Bank of New York Mellon's MIRA Pharmaceuticals position peaked at $12.7K in Q2 2024.
  • 15 funds tracked by Wall St. Rank held MIRA Pharmaceuticals as of Q3 2024.

Based on Bank of New York Mellon's 13F filing for Q3 2024, filed 12 Nov 2024.